Updated: 16th July 2026
Reviewed by: David Small BSc (Hons), MSc, MTOPRA (Founder and CEO)
Why an MDR Technical File Is Never "Finished"
Many manufacturers view the technical file as a project that ends once CE marking has been achieved. In practice, Regulation (EU) 2017/745 (EU MDR) requires technical documentation to be maintained throughout the entire lifecycle of the medical device. As products evolve, manufacturing processes change and new evidence becomes available, the technical documentation must continue to accurately demonstrate that the device remains safe, performs as intended and complies with the applicable regulatory requirements.
Technical documentation should therefore be treated as a living collection of evidence rather than a static set of documents. Every significant change to the device or its supporting evidence should trigger a review of the technical file to determine whether updates are required. Maintaining accurate documentation not only supports ongoing compliance but also helps manufacturers respond efficiently to regulatory inspections, customer enquiries and future conformity assessments.
A well-maintained technical file provides confidence that every aspect of the device remains aligned. The intended purpose, risk management documentation, clinical evaluation, verification and validation evidence, labelling, instructions for use and post-market surveillance activities should all remain consistent as the product develops. Allowing individual documents to evolve independently can quickly lead to inconsistencies that increase regulatory risk and make future updates significantly more difficult.
Manufacturers should establish documented processes for reviewing and updating technical documentation whenever changes occur. Integrating technical documentation maintenance into the quality management system ensures that design changes, supplier updates, complaint trends, corrective actions and regulatory developments are reflected across all relevant documentation in a controlled and traceable manner.
Ultimately, maintaining an MDR technical file is not simply about retaining CE marking. It is about ensuring the documentation continues to accurately represent the medical device throughout its commercial life, providing objective evidence that the product remains compliant, safe and effective as new information becomes available.
New to the EU MDR?
A strong technical file is only one part of MDR compliance. For a complete guide to Regulation (EU) 2017/745, including device classification, Article 10 obligations, GSPRs, clinical evaluation, UDI, EUDAMED and CE marking requirements, explore our EU MDR for Beginners Guide.
Need to Build Your Technical File First?
Before maintaining technical documentation, manufacturers should ensure it has been structured correctly. Our guide explains how to organise an MDR technical file in accordance with Annexes II and III of Regulation (EU) 2017/745.
Read our guide to structuring a medical device technical file →
When Should Technical Documentation Be Updated?
Maintaining an MDR technical file is an ongoing responsibility rather than an annual exercise. Manufacturers should establish procedures to review technical documentation whenever significant changes occur that could affect the safety, performance or regulatory compliance of the device. Waiting until a surveillance audit or regulatory inspection to update documentation often leads to inconsistencies, missing evidence and unnecessary compliance risks.
Not every change requires a complete revision of the technical file, but every change should be assessed to determine whether the existing documentation continues to accurately reflect the device. Implementing a formal change assessment process helps ensure updates are proportionate, documented and fully traceable.
Common situations that should trigger a review of technical documentation include:
Design and Product Changes
Changes to the device design, intended purpose, materials, dimensions, software functionality or accessories should always prompt a review of the technical documentation. Even relatively small design modifications may affect risk management, verification testing, clinical evidence or labelling.
Manufacturing and Supplier Changes
Changes to manufacturing processes, production sites, critical suppliers or component specifications can affect product consistency and regulatory compliance. Manufacturers should evaluate whether manufacturing documentation, validation reports or other supporting evidence requires updating following these changes.
New Clinical and Post-Market Evidence
Technical documentation should evolve as new evidence becomes available. Complaint trends, post-market surveillance activities, Post-Market Clinical Follow-up (PMCF) findings, published literature or vigilance investigations may identify new risks or demonstrate changes in clinical performance that should be reflected throughout the technical documentation.
Regulatory and Standards Updates
Medical device regulations continue to evolve through new MDCG guidance documents, revised harmonised standards and Common Specifications. Manufacturers should regularly assess whether changes in the regulatory landscape affect their existing technical documentation or require updates to demonstrate continued compliance.
Labelling and Documentation Revisions
Changes to Instructions for Use (IFUs), packaging artwork, symbols, translations or product claims should be reviewed alongside the wider technical documentation to ensure consistency. Even editorial changes can have implications if they alter the intended purpose, warnings or information supplied to users.
Corrective and Preventive Actions (CAPA)
Corrective actions arising from internal audits, supplier issues, customer complaints or nonconformities often require corresponding updates to technical documentation. Linking CAPA activities with document control helps ensure improvements are fully implemented and appropriately documented.
Rather than viewing these events as isolated updates, manufacturers should incorporate technical documentation reviews into their wider change management process. Assessing documentation as part of every significant change helps maintain consistency across the technical file and reduces the likelihood of compliance issues developing over time.
Establishing Effective Document Control
Maintaining an MDR technical file requires more than simply updating documents when changes occur. Manufacturers need a structured document control process that ensures every revision is reviewed, approved, traceable and communicated to the appropriate personnel. Without effective document control, technical documentation can quickly become inconsistent, with different versions of documents containing conflicting information about the same device.
Every document within the technical file should have a clearly defined owner who is responsible for ensuring its accuracy and reviewing it when changes occur. Although regulatory affairs often coordinates technical documentation, maintaining an MDR technical file is a cross-functional responsibility involving engineering, quality assurance, manufacturing, clinical, post-market surveillance and supply chain teams. Assigning ownership helps ensure that updates are completed promptly and that accountability is clearly defined.
Version control is equally important. Each revision should be uniquely identified, approved before release and supported by a documented revision history explaining what has changed and why. Maintaining historical versions allows manufacturers to demonstrate the evolution of the device and provides valuable evidence during regulatory inspections, internal investigations or customer enquiries.
Document control should also be closely integrated with formal change management procedures. Whenever a design change, supplier modification, manufacturing update or corrective action is approved, the impact on the technical documentation should be assessed before the change is implemented. This ensures that all affected documents are reviewed together rather than being updated independently over time.
Manufacturers should also establish periodic reviews of their technical documentation, even when no significant changes have occurred. Scheduled reviews provide an opportunity to confirm that referenced standards remain current, supporting evidence is still valid, hyperlinks and cross-references are accurate, and documentation continues to reflect the device as it is currently manufactured and supplied.
By implementing robust document control practices, manufacturers can ensure their technical documentation remains accurate, consistent and fully traceable throughout the product lifecycle. This not only supports ongoing MDR compliance but also reduces the administrative burden of future updates by preventing documentation from becoming fragmented or outdated.
Keeping Technical Documentation Aligned Across the Device Lifecycle
One of the biggest challenges in maintaining an MDR technical file is ensuring that changes made to one document are consistently reflected throughout the rest of the technical documentation. Medical device compliance relies on multiple documents supporting the same intended purpose, safety profile and clinical claims. If these documents become misaligned over time, manufacturers can inadvertently introduce inconsistencies that increase regulatory risk.
For example, a design modification may initially appear to affect only the engineering documentation. However, that same change could also require updates to the Risk Management File, verification and validation reports, Instructions for Use (IFU), labelling, clinical evaluation, General Safety and Performance Requirements (GSPR) checklist and post-market surveillance documentation. Failing to assess the wider impact of a change may result in different documents describing the device in conflicting ways.
Manufacturers should therefore adopt a holistic approach to technical documentation maintenance. Rather than reviewing individual documents in isolation, every significant change should trigger an assessment of all related documentation to determine whether supporting evidence, conclusions or cross-references also require revision.
The following areas are commonly interconnected within an MDR technical file:
| If this changes… | Review these documents… |
|---|---|
| Intended purpose | Clinical Evaluation, GSPR Checklist, IFU, Labelling, Risk Management File, PMS documentation |
| Device design or materials | Risk Management File, Biological Evaluation, Verification & Validation, Clinical Evaluation, Manufacturing Information |
| Manufacturing process | Manufacturing Documentation, Process Validation, Risk Management, PMS records |
| Software functionality | Software Documentation, Risk Management, Verification & Validation, Cybersecurity documentation, IFU |
| New clinical or PMS evidence | Clinical Evaluation, Risk Management File, PMCF documentation, GSPR Checklist |
| Labelling or IFU | GSPR Checklist, Clinical Evaluation, Risk Management, Product Packaging and Translations |
Maintaining alignment across the technical file is also important for demonstrating traceability. Regulators expect manufacturers to be able to show how identified risks are controlled, how those controls have been verified, how clinical evidence supports safety and performance, and how post-market data confirms that the device continues to perform as intended. Consistent documentation provides a clear chain of evidence linking these activities together.
Developing a structured change impact assessment process can significantly reduce the likelihood of inconsistencies. Before approving any significant modification, manufacturers should identify every document that may be affected, assign responsibility for the necessary updates and verify that all revisions have been completed before the updated documentation is released. This coordinated approach helps ensure the technical file continues to present a complete and accurate picture of the device throughout its lifecycle.
Keeping Your GSPR Checklist Up to Date
Whenever technical documentation changes, manufacturers should review their General Safety and Performance Requirements (GSPR) Checklist to ensure the evidence supporting compliance remains complete, accurate and fully traceable.
Managing Device Variants and Product Families
As medical device portfolios grow, maintaining technical documentation becomes increasingly complex. Many manufacturers market products that share the same intended purpose and core design but are available in different sizes, configurations, accessories or software versions. While grouping these products within a single technical file or product family can simplify documentation, it also requires careful management to ensure every variant remains adequately supported.
Manufacturers should clearly define which products are covered by the technical documentation and identify any differences that may influence safety, performance or regulatory compliance. Although many documents can be shared across a product family, evidence should always demonstrate that the conclusions remain applicable to every device included within the scope of the technical file.
For example, introducing a new device size may appear to be a relatively minor change. However, the modification could require updates to verification and validation testing, risk management, packaging specifications, labelling or clinical justification. Similarly, adding a new accessory or introducing an additional software feature may affect multiple areas of the technical documentation, even if the underlying device remains largely unchanged.
Manufacturers should also maintain a clear configuration management process that records the relationship between each device variant and the supporting evidence within the technical file. This helps demonstrate that every marketed configuration has been appropriately assessed and that no variants fall outside the scope of the documented evidence.
Where technical documentation supports multiple products, periodic reviews should confirm that each variant remains current. Devices that have been discontinued, significantly modified or superseded should be clearly identified, while newly introduced models should only be added once all supporting documentation has been reviewed and updated as necessary.
By actively managing product families and device variants, manufacturers can reduce duplication of documentation while maintaining confidence that every product placed on the market continues to be supported by complete, accurate and up-to-date technical documentation.
Responding to Regulatory and Standards Changes
Medical device regulations are continually evolving through updated harmonised standards, new MDCG guidance documents, Common Specifications and amendments to existing legislation. Although a device may have successfully achieved CE marking, manufacturers remain responsible for monitoring regulatory developments and assessing whether changes affect the technical documentation supporting their products.
Establishing a formal process for regulatory surveillance helps ensure that new requirements are identified promptly and assessed consistently. This may involve subscribing to regulatory updates, monitoring publications from the European Commission and Medical Device Coordination Group (MDCG), reviewing revisions to harmonised standards and maintaining awareness of guidance issued by Competent Authorities. Responsibility for monitoring regulatory changes should be clearly assigned within the organisation to ensure new information is evaluated in a timely manner.
When new guidance or standards are published, manufacturers should carry out a documented impact assessment to determine whether changes to the technical documentation are necessary. In some cases, the update may require only minor revisions, such as referencing a newer edition of a standard. In others, it may necessitate additional verification testing, revised risk assessments, updated clinical evidence or changes to labelling and Instructions for Use.
Manufacturers should also recognise that regulatory expectations develop over time. Advances in clinical practice, improvements in testing methodologies and evolving industry best practice may all influence how compliance is demonstrated. Regularly reviewing technical documentation against current expectations helps ensure it continues to reflect the state of the art and supports the ongoing safety and performance of the device.
Rather than treating regulatory change as a reactive exercise, manufacturers should incorporate periodic regulatory reviews into their quality management system. Combining regulatory surveillance with scheduled technical documentation reviews allows updates to be planned proactively, reducing the risk of non-compliance and ensuring documentation remains aligned with current regulatory expectations throughout the device lifecycle.
Supporting Technical Documentation with ISO 13485
Effective document control, change management and continual improvement are fundamental principles of ISO 13485. A well-implemented quality management system helps ensure technical documentation remains accurate throughout the product lifecycle.
Developing a Technical Documentation Maintenance Programme
Maintaining technical documentation should be a planned and structured activity rather than something that only happens when a regulatory issue arises. Establishing a formal technical documentation maintenance programme helps ensure that updates are made consistently, responsibilities are clearly defined and documentation remains aligned with the current state of the device throughout its lifecycle.
A successful maintenance programme begins by assigning ownership for the technical file. While Regulatory Affairs or Quality Assurance often coordinate document updates, maintaining compliant technical documentation requires input from multiple departments, including design and development, manufacturing, clinical, post-market surveillance, purchasing and supply chain. Defining clear responsibilities ensures that changes are communicated promptly and that no aspect of the documentation is overlooked.
Manufacturers should also establish a schedule for routine documentation reviews. Although significant design or manufacturing changes should always trigger an immediate assessment, periodic reviews provide an opportunity to verify that documentation remains accurate, references the latest applicable standards and reflects current manufacturing practices and post-market experience. These reviews should be documented and retained as evidence that technical documentation is being actively maintained.
An effective maintenance programme should also incorporate formal change impact assessments. Before implementing any significant change, manufacturers should evaluate which documents are affected, identify the evidence that requires updating and verify that all revisions have been completed before the updated product is released. This structured approach helps maintain consistency across the technical file and reduces the risk of conflicting information.
Many manufacturers find it helpful to use a simple maintenance checklist as part of their periodic review process. Typical review activities include:
- Confirm the intended purpose remains unchanged and is consistently described throughout the technical documentation.
- Verify that risk management documentation reflects the current design and any new post-market information.
- Review clinical evidence to ensure conclusions remain current and adequately support the device.
- Check that verification and validation reports remain applicable following design or manufacturing changes.
- Confirm that labelling, Instructions for Use (IFU) and packaging information remain accurate and consistent.
- Review post-market surveillance data, complaints and CAPA activities for changes that may require documentation updates.
- Verify that referenced standards, guidance documents and regulatory requirements remain current.
- Ensure document version numbers, revision histories and cross-references remain accurate.
By embedding these activities into normal quality management processes, manufacturers can move away from reactive document updates and establish a culture of continual compliance. Over time, this reduces the effort required to maintain technical documentation, improves internal efficiency and provides greater confidence that the technical file accurately represents the device at every stage of its lifecycle.
Common Mistakes When Maintaining Technical Documentation
Maintaining technical documentation over many years can be challenging, particularly as products evolve and multiple departments contribute to updates. Even manufacturers with well-established quality management systems can introduce inconsistencies if changes are not managed in a coordinated manner. Identifying common maintenance mistakes can help organisations strengthen their document control processes and reduce the risk of compliance issues developing over time.
Updating Individual Documents in Isolation
One of the most common maintenance errors is updating a single document without considering its impact on the wider technical file. For example, revising the Instructions for Use (IFU) without reviewing the Clinical Evaluation Report, Risk Management File or GSPR Checklist can result in conflicting information across the documentation. Every significant change should be assessed to determine which supporting documents also require revision.
Delaying Documentation Updates
Technical documentation should be updated as changes occur, not months later when preparing for an audit or regulatory submission. Delayed updates increase the likelihood that supporting evidence becomes inconsistent or that important decisions are forgotten. Integrating documentation reviews into change management activities helps ensure records remain accurate and current.
Failing to Monitor External Changes
Manufacturers sometimes focus solely on internal changes while overlooking developments in the wider regulatory landscape. New harmonised standards, MDCG guidance documents, Common Specifications and changes to legislation may all require technical documentation to be reviewed. Establishing a formal regulatory surveillance process helps ensure these changes are identified and assessed promptly.
Weak Version Control
Poor version control can quickly undermine confidence in technical documentation. Missing revision histories, unclear approval records or multiple uncontrolled copies of the same document make it difficult to demonstrate which version is current. Maintaining robust document control procedures helps preserve traceability and ensures every revision can be clearly justified.
Overlooking Supplier and Manufacturing Changes
Changes to suppliers, raw materials, manufacturing equipment or production processes may appear operational, but they can also affect the technical documentation supporting the device. Manufacturers should routinely assess whether these changes influence risk management, verification activities, manufacturing information or other supporting evidence.
Treating Technical Documentation as a Regulatory Exercise
Perhaps the most significant mistake is viewing technical documentation as something maintained solely to satisfy regulators. In reality, a well-maintained technical file provides an accurate record of how the device has evolved throughout its lifecycle and supports better decision-making across design, manufacturing, quality and post-market activities. Organisations that integrate technical documentation into their everyday quality processes are typically better prepared for regulatory inspections and more responsive when changes occur.
By avoiding these common pitfalls and adopting a proactive approach to documentation maintenance, manufacturers can ensure their technical files remain accurate, consistent and capable of demonstrating ongoing compliance throughout the commercial life of the device.
MDR Technical Documentation Maintenance Checklist
Maintaining technical documentation is an ongoing process that extends throughout the commercial life of a medical device. Establishing a structured review programme helps manufacturers ensure their technical file remains accurate, complete and capable of demonstrating continued compliance with Regulation (EU) 2017/745.
The following checklist can be used as part of periodic technical documentation reviews or following significant product changes.
| Review Area | Questions to Consider |
|---|---|
| Intended Purpose | Does the intended purpose remain accurate and consistent across all documentation? |
| Device Design | Have any design, material or software changes been fully reflected throughout the technical file? |
| Manufacturing Information | Have manufacturing processes, suppliers or critical components changed since the last review? |
| Risk Management | Does the Risk Management File reflect current product risks, complaint trends and post-market evidence? |
| Clinical Evaluation | Has new clinical evidence, published literature or PMCF data been assessed and incorporated where appropriate? |
| Verification & Validation | Do existing test reports continue to support the current device configuration? |
| Labelling & IFU | Are labelling, symbols, translations and Instructions for Use consistent with the current product? |
| Post-Market Surveillance | Have complaint data, vigilance activities and PMS findings been reviewed for documentation updates? |
| Standards & Guidance | Are all referenced harmonised standards, MDCG guidance documents and Common Specifications current? |
| Document Control | Are document owners, revision histories, approvals and cross-references accurate and up to date? |
Completing these reviews at planned intervals, as well as following significant changes, helps manufacturers maintain confidence that their technical documentation continues to represent the device as it is currently designed, manufactured and supplied. A proactive maintenance programme also reduces the risk of inconsistencies developing over time and makes future regulatory submissions, inspections and internal reviews significantly more efficient.
Clinical Evidence Must Be Maintained Too
Maintaining technical documentation also means keeping your Clinical Evaluation current. Learn how manufacturers should review clinical evidence, update Clinical Evaluation Reports (CERs) and demonstrate continued compliance throughout the medical device lifecycle.
How Patient Guard Can Help
Keeping technical documentation up to date can become increasingly challenging as medical devices evolve, regulatory expectations change and post-market evidence grows. Many manufacturers have robust documentation at the point of CE marking but struggle to maintain consistency across the technical file as products, suppliers and processes change over time.
Patient Guard supports manufacturers throughout the entire medical device lifecycle by providing practical regulatory and quality management expertise. Whether you require an independent review of your existing technical documentation or ongoing support to maintain compliance, our consultants work alongside your team to ensure your technical file continues to accurately reflect your device and meets the requirements of Regulation (EU) 2017/745.
Our technical documentation services include:
- MDR technical documentation gap assessments
- Ongoing technical file maintenance and document updates
- Change impact assessments following design or manufacturing changes
- Clinical Evaluation Report (CER) updates
- Risk Management File reviews and updates
- GSPR checklist reviews and traceability assessments
- Post-Market Surveillance (PMS) and PMCF documentation updates
- Technical documentation reviews prior to regulatory submissions
- Independent regulatory compliance reviews
Whether you are preparing for certification, introducing design changes or simply want confidence that your technical documentation remains current, Patient Guard can help you establish a practical and sustainable approach to maintaining compliance throughout the product lifecycle.
Frequently Asked Questions
There is no fixed review frequency specified within the EU MDR. However, manufacturers should review their technical documentation whenever significant changes occur to the device, manufacturing processes, suppliers or regulatory requirements. In addition, many organisations perform planned annual reviews to ensure documentation remains accurate, consistent and aligned with current regulatory expectations.
Not every design change requires a complete revision of the technical file, but every change should be assessed to determine its regulatory impact. Even relatively minor modifications may affect risk management, clinical evaluation, verification testing, labelling or other supporting documentation. A documented change impact assessment helps ensure all necessary updates are identified.
Although Regulatory Affairs or Quality Assurance often coordinates technical documentation, maintaining an MDR technical file is a cross-functional responsibility. Design engineers, manufacturing teams, clinical specialists, post-market surveillance personnel and supply chain functions may all contribute information that affects the technical documentation throughout the device lifecycle.
Yes. Changes to critical suppliers, materials, manufacturing processes or components may affect multiple areas of the technical documentation. Manufacturers should assess whether supplier changes require updates to manufacturing information, risk management, verification and validation evidence or other supporting documentation before implementing the change.
Software updates should be assessed through the manufacturer’s change management process to determine their impact on technical documentation. Depending on the nature of the update, revisions may be required to software documentation, verification and validation reports, cybersecurity documentation, risk management, clinical evaluation or labelling.
Manufacturers must retain the technical documentation, EU Declaration of Conformity and other relevant records for at least 10 years after the last device covered by the declaration has been placed on the market. For implantable devices, this retention period increases to 15 years.
One of the most common mistakes is updating individual documents in isolation. Technical documentation is interconnected, meaning changes to one document often affect several others. Maintaining consistency across the entire technical file is essential for demonstrating ongoing compliance and avoiding conflicting information.
Yes. Periodic reviews are considered good practice, even when no significant changes have occurred. Regular reviews help confirm that referenced standards remain current, supporting evidence is still valid, document cross-references remain accurate and the technical documentation continues to reflect the device as it is currently manufactured and supplied.
Yes. Patient Guard provides independent technical documentation reviews, gap assessments and ongoing maintenance support for medical device manufacturers. Our consultants can identify areas for improvement, assist with document updates and help ensure technical documentation remains compliant throughout the product lifecycle.
Achieving CE marking is not the end of the regulatory process. Manufacturers remain responsible for ensuring their technical documentation accurately reflects the current device throughout its lifecycle. Maintaining up-to-date documentation supports continued compliance with Regulation (EU) 2017/745, facilitates regulatory inspections and ensures that changes to the device are appropriately documented and justified.
References
This guide is based on the following legislation, international standards and official regulatory guidance relating to preparing robust technical documentation and achieving successful conformity assessment under Regulation (EU) 2017/745 (MDR).
| Organisation | Reference | Why it's relevant |
|---|---|---|
| European Union | Regulation (EU) 2017/745 on Medical Devices (MDR) | Defines the legal requirements for technical documentation, including the content specified in Annex II and the post-market surveillance documentation required by Annex III. |
| European Commission | MDCG Endorsed Documents and Other Guidance | Provides official Medical Device Coordination Group (MDCG) guidance supporting the preparation of technical documentation, clinical evaluation, post-market surveillance and conformity assessment under the MDR. |
| European Commission | Notified Bodies for Medical Devices | Provides official information on the designation and responsibilities of Notified Bodies responsible for reviewing technical documentation and conducting conformity assessments under the MDR. |
| International Organization for Standardization (ISO) | ISO 13485:2016 – Medical Devices – Quality Management Systems – Requirements for Regulatory Purposes | Defines the internationally recognised Quality Management System requirements supporting document control, design and development, corrective actions and the maintenance of compliant technical documentation. |
| International Organization for Standardization (ISO) | ISO 14971:2019 – Medical Devices – Application of Risk Management to Medical Devices | Provides the internationally recognised framework for documenting, reviewing and maintaining risk management evidence that forms a fundamental part of MDR technical documentation. |
Technical documentation requirements, conformity assessment expectations and regulatory guidance continue to evolve. Manufacturers should always consult the latest published legislation, recognised standards and official guidance when preparing technical documentation for Notified Body review and maintaining compliance throughout the product lifecycle.
Patient Guards Recent Posts
Cosmetic Product Safety Report (CPSR): A Complete Guide to UK Cosmetic Compliance
Before a cosmetic product can legally be placed on the UK market, manufacturers and Responsible Persons must demonstrate that it is safe for human use under normal or reasonably foreseeable conditions. The Cosmetic Product Safety Report (CPSR) is one of the most important regulatory documents required under the UK Cosmetics Regulation. This guide explains what a CPSR is, who can prepare one, what information it must contain, how it relates to the Product Information File (PIF) and how it supports legal cosmetic compliance.
IVDR PMPF Explained: A Complete Guide to Post-Market Performance Follow-up
Post-Market Performance Follow-up (PMPF) is a fundamental requirement under the EU In Vitro Diagnostic Regulation (IVDR), ensuring that manufacturers continually monitor the scientific validity, analytical performance and clinical performance of their in vitro diagnostic medical devices after CE marking. This guide explains IVDR PMPF requirements, PMPF Plans, PMPF Reports, Annex XIII expectations and how ongoing performance monitoring supports continued regulatory compliance throughout the device lifecycle.
IVDR Scientific Validity Explained: A Complete Guide for Manufacturers
Scientific Validity is the first pillar of IVDR Performance Evaluation and provides the scientific foundation demonstrating that an analyte or biomarker is associated with a specific clinical condition or physiological state. This guide explains Scientific Validity under Regulation (EU) 2017/746, including literature reviews, Scientific Validity Reports, Annex XIII requirements, evidence appraisal and how Scientific Validity supports successful CE marking.
Patient Guards Related Services
Patient Guards Regulatory Tools
Need Training?
Do you need training on Quality Management Systems or EU MDR/ EU IVDR? then check out our training courses.
